Clinical Trials Directory

Trials / Completed

CompletedNCT02716909

Pessary in Singleton Gestations With Short Cervix Without Prior Preterm Birth

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
300 (actual)
Sponsor
Federico II University · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Spontaneous preterm birth (SPTB) remains the number one cause of perinatal mortality in many countries, including the United States. In singleton gestations a short cervical length (CL) on transvaginal ultrasound (TVU) has been shown to be a good predictor of SPTB. The cervical pessary is a silicone device that has been used to prevent SPTB. The efficacy of cervical pessary has been assessed in several populations including singletons with short CL, unselected twins, twins with a short CL, and triplet pregnancies. Several randomized clinical trials (RCTs) have been published, and several are ongoing. However, no consensus on the use of cervical pessary in pregnancy or guidelines for management have been assessed.

Conditions

Interventions

TypeNameDescription
DEVICECervical pessaryThe cervical pessary is a silicone device that has been used to prevent SPTB Pessary will be placed between 18 and 23 6/7 weeks gestation, and will be removed during the 37th week of pregnancy (or earlier, if indicated)

Timeline

Start date
2016-03-01
Primary completion
2017-05-01
Completion
2017-07-01
First posted
2016-03-23
Last updated
2018-06-18

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02716909. Inclusion in this directory is not an endorsement.

Pessary in Singleton Gestations With Short Cervix Without Prior Preterm Birth (NCT02716909) · Clinical Trials Directory